1
|
An Z, Miao M, Sun F, Lan XB, Yu JQ, Guo X, Zhang J. Copper-catalyzed oxidative cyclization of 2-(1 H-pyrrol-1-yl)aniline and alkylsilyl peroxides: a route to pyrrolo[1,2- a]quinoxalines. Org Biomol Chem 2024; 22:2370-2374. [PMID: 38416487 DOI: 10.1039/d3ob01934a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/29/2024]
Abstract
An efficient method was developed for the one-pot construction of pyrrolo[1,2-a]quinoxalines via a Cu(II)-catalyzed domino reaction between 2-(1H-pyrrol-1-yl)anilines and alkylsilyl peroxides. This reaction proceeds through C-C bond cleavage and new C-C and C-N bond formation. A mechanistic study suggests that alkyl radical species participate in the cascade reaction.
Collapse
Affiliation(s)
- Zhenyu An
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Man Miao
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Fengkai Sun
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Xiao-Bing Lan
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Jian-Qiang Yu
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Xiaoli Guo
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
| | - Jian Zhang
- College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
- Medicinal Chemistry and Bioinformatics Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| |
Collapse
|
2
|
Li Y, He L, Qin H, Liu Y, Yang B, Xu Z, Yang D. A Facile Ugi/Ullmann Cascade Reaction to Access Fused Indazolo-Quinoxaline Derivatives with Potent Anticancer Activity. Molecules 2024; 29:464. [PMID: 38257377 PMCID: PMC10820152 DOI: 10.3390/molecules29020464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2023] [Revised: 01/10/2024] [Accepted: 01/16/2024] [Indexed: 01/24/2024] Open
Abstract
A facile methodology for the construction of a complex heterocycle indazolo-fused quinoxalinone has been developed via an Ugi four-component reaction (U-4CR) followed by an intramolecular Ullmann reaction. The expeditious process features an operationally simple approach, time efficiency, and a broad substrate scope. Biological activity was evaluated and demonstrated that compound 6e inhibits human colon cancer cell HCT116 proliferation with an IC50 of 2.1 μM, suggesting potential applications for developing a drug lead in medicinal chemistry.
Collapse
Affiliation(s)
- Yong Li
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
- School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China
| | - Liujun He
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| | - Hongxia Qin
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| | - Yao Liu
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| | - Binxin Yang
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| | - Zhigang Xu
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| | - Donglin Yang
- College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing University of Arts and Sciences, Chongqing 402160, China
| |
Collapse
|
3
|
Guillon J, Le Borgne M, Milano V, Guédin-Beaurepaire A, Moreau S, Pinaud N, Ronga L, Savrimoutou S, Albenque-Rubio S, Marchivie M, Kalout H, Walker C, Chevallier L, Buré C, Largy E, Gabelica V, Mergny JL, Baylot V, Ferrer J, Idrissi Y, Chevret E, Cappellen D, Desplat V, Schelz Z, Zupkó I. New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex. Pharmaceuticals (Basel) 2023; 17:30. [PMID: 38256866 PMCID: PMC10819771 DOI: 10.3390/ph17010030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2023] [Revised: 12/13/2023] [Accepted: 12/21/2023] [Indexed: 01/24/2024] Open
Abstract
The syntheses of novel 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazolines 12 and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinolines 13 are reported here in six steps starting from various halogeno-quinazoline-2,4-(1H,3H)-diones or substituted anilines. The antiproliferative activities of the products were determined in vitro against a panel of breast (MCF-7 and MDA-MB-231), human adherent cervical (HeLa and SiHa), and ovarian (A2780) cell lines. Disubstituted 6- and 7-phenyl-bis(3-dimethylaminopropyl)aminomethylphenyl-quinazolines 12b, 12f, and 12i displayed the most interesting antiproliferative activities against six human cancer cell lines. In the series of quinoline derivatives, 6-phenyl-bis(3-dimethylaminopropyl)aminomethylphenylquinoline 13a proved to be the most active. G-quadruplexes (G4) stacked non-canonical nucleic acid structures found in specific G-rich DNA, or RNA sequences in the human genome are considered as potential targets for the development of anticancer agents. Then, as small aza-organic heterocyclic derivatives are well known to target and stabilize G4 structures, their ability to bind G4 structures have been determined through FRET melting, circular dichroism, and native mass spectrometry assays. Finally, telomerase inhibition ability has been also assessed using the MCF-7 cell line.
Collapse
Affiliation(s)
- Jean Guillon
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Marc Le Borgne
- Small Molecules for Biological Targets Team, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, CNRS 5286, INSERM 1052, Université Claude Bernard Lyon 1, Univ. Lyon, F-69373 Lyon, France
| | - Vittoria Milano
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Aurore Guédin-Beaurepaire
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Stéphane Moreau
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Noël Pinaud
- ISM—CNRS UMR 5255, Univ. Bordeaux, F-33405 Talence, France;
| | - Luisa Ronga
- E2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l’Adour, F-64053 Pau, France;
| | - Solène Savrimoutou
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Sandra Albenque-Rubio
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | | | - Haouraa Kalout
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Charley Walker
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Louise Chevallier
- INSERM, CNRS, ARNA, U1212, UMR 5320, UFR des Sciences Pharmaceutiques, Univ. Bordeaux, F-33076 Bordeaux, France; (J.G.); (V.M.); (A.G.-B.); (S.M.); (S.S.); (S.A.-R.); (H.K.); (C.W.); (L.C.)
| | - Corinne Buré
- CNRS, INSERM, IECB, US1, UAR 3033, Univ. Bordeaux, F-33600 Pessac, France;
| | - Eric Largy
- CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France; (E.L.); (V.G.)
| | - Valérie Gabelica
- CNRS, INSERM, ARNA, UMR 5320, U1212, IECB, Univ. Bordeaux, F-33600 Pessac, France; (E.L.); (V.G.)
| | - Jean-Louis Mergny
- Ecole Polytechnique, Laboratoire d’Optique et Biosciences, CNRS, INSERM, Institut Polytechnique de Paris, F-91120 Palaiseau, France;
| | - Virginie Baylot
- Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, CNRS UMR7258, Inserm U1068, Univ. Aix Marseille, F-13009 Marseille, France;
| | - Jacky Ferrer
- INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France; (J.F.); (Y.I.); (E.C.); (D.C.); (V.D.)
| | - Yamina Idrissi
- INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France; (J.F.); (Y.I.); (E.C.); (D.C.); (V.D.)
| | - Edith Chevret
- INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France; (J.F.); (Y.I.); (E.C.); (D.C.); (V.D.)
| | - David Cappellen
- INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France; (J.F.); (Y.I.); (E.C.); (D.C.); (V.D.)
- Service Tumor Biology and Tumor Bank Laboratory, Groupe Hospitalier Bordeaux, CHU Bordeaux, F-33000 Bordeaux, France
| | - Vanessa Desplat
- INSERM UMR1312, BRIC, Bordeaux Institute of Oncology, Univ. Bordeaux, F-33076 Bordeaux, France; (J.F.); (Y.I.); (E.C.); (D.C.); (V.D.)
| | - Zsuzsanna Schelz
- Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary;
| | - István Zupkó
- Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, Hungary;
| |
Collapse
|
4
|
Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, Thareja S, Yadav JP, Pathak P, Grishina M, Verma A, Khalilullah H, Jaremko M, Emwas AH, Kumar P. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals (Basel) 2023; 16:299. [PMID: 37259442 PMCID: PMC9965678 DOI: 10.3390/ph16020299] [Citation(s) in RCA: 19] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 01/26/2023] [Accepted: 01/28/2023] [Indexed: 07/30/2023] Open
Abstract
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, and suffer from resistance. So, there is a dire need to develop safer and target-specific anticancer drugs. More than 85% of all physiologically active pharmaceuticals are heterocycles or contain at least one heteroatom. Nitrogen heterocycles constituting the most common heterocyclic framework. In this study, we have compiled the FDA approved heterocyclic drugs with nitrogen atoms and their pharmacological properties. Moreover, we have reported nitrogen containing heterocycles, including pyrimidine, quinolone, carbazole, pyridine, imidazole, benzimidazole, triazole, β-lactam, indole, pyrazole, quinazoline, quinoxaline, isatin, pyrrolo-benzodiazepines, and pyrido[2,3-d]pyrimidines, which are used in the treatment of different types of cancer, concurrently covering the biochemical mechanisms of action and cellular targets.
Collapse
Affiliation(s)
- Adarsh Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Ankit Kumar Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Harshwardhan Singh
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Veena Vijayan
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Deepak Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jashwanth Naik
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Suresh Thareja
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| | - Jagat Pal Yadav
- Pharmacology Research Laboratory, Faculty of Pharmaceutical Sciences, Rama University, Kanpur 209217, India
| | - Prateek Pathak
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Maria Grishina
- Laboratory of Computational Modeling of Drugs, Higher Medical and Biological School, South Ural State University, 454008 Chelyabinsk, Russia
| | - Amita Verma
- Bioorganic and Medicinal Chemistry Research Laboratory, Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India
| | - Habibullah Khalilullah
- Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unayzah 51911, Saudi Arabia
| | - Mariusz Jaremko
- Smart-Health Initiative and Red Sea Research Center, Division of Biological and Environmental Sciences and Engineering, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Abdul-Hamid Emwas
- Core Labs, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia
| | - Pradeep Kumar
- Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Ghudda, Bathinda 151401, India
| |
Collapse
|
5
|
Hao D, Yang Z, Liu Y, Li Y, Liu Y, Liu P. Copper-promoted C1−H amination of pyrrolo[1,2-a]quinoxaline with N‑fluorobenzenesulfonimide. J Mol Struct 2022; 1267:133636. [DOI: 10.1016/j.molstruc.2022.133636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
6
|
Sanachai K, Mahalapbutr P, Tabtimmai L, Seetaha S, Kittikool T, Yotphan S, Choowongkomon K, Rungrotmongkol T. Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds. ACS Omega 2022; 7:33587-33598. [PMID: 36157733 PMCID: PMC9494680 DOI: 10.1021/acsomega.2c04769] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Accepted: 08/26/2022] [Indexed: 06/16/2023]
Abstract
Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3. Therefore, to decrease the risk of these diseases, targeting this pathway using JAK2/3 inhibitors could serve as a valuable research tool. Herein, we used a combination of the computational and biological approaches to identify the quinoxalinone-based dual inhibitors of JAK2/3. First, an in-house library of 49 quinoxalinones was screened by molecular docking. Then, the inhibitory activities of 17 screened compounds against both JAKs as well as against two human erythroleukemia cell lines, TF1 and HEL were examined. The obtained results revealed that several quinoxalinones could potentially inhibit JAK2/3, and among them, ST4j showed strong inhibition against JAKs with the IC50 values of 13.00 ± 1.31 nM for JAK2 and 14.86 ± 1.29 nM for JAK3, which are better than ruxolitinib and tofacitinib. In addition, ST4j potentially inhibited TF1 cells (IC50 of 15.53 ± 0.82 μM) and HEL cells (IC50 of 17.90 ± 1.36 μM), similar to both tofacitinib ruxolitinib. Mechanistically, ST4j inhibited JAK2 autophosphorylation and induced cell apoptosis in dose- and time-dependent manners. From molecular dynamics simulations, ST4j was mainly stabilized by van der Waals interactions, and its hydroxyl group could form hydrogen bonds in the hinge region at residues S936 and R938 of JAK2. This research highlights the potential of ST4j to be a novel therapeutic agent for the treatment of lymphoid-derived diseases and leukemia cancer.
Collapse
Affiliation(s)
- Kamonpan Sanachai
- Center
of Excellence in Structural and Computational Biology Research Unit,
Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand
| | - Panupong Mahalapbutr
- Department
of Biochemistry, and Center for Translational Medicine, Faculty of
Medicine, Khon Kaen University, Khon Kaen 40002, Thailand
| | - Lueacha Tabtimmai
- Department
of Biotechnology, Faculty of Applied Science, King Mongkut’s University of Technology of North Bangkok, Bangkok 10800, Thailand
| | - Supaphorn Seetaha
- Department
of Biochemistry, Faculty of Science, Kasetsart
University, Bangkok 10900, Thailand
| | - Tanakorn Kittikool
- Department
of Chemistry and Center of Excellence for Innovation in Chemistry,
Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand
| | - Sirilata Yotphan
- Department
of Chemistry and Center of Excellence for Innovation in Chemistry,
Faculty of Science, Mahidol University, Rama VI Road, Bangkok 10400, Thailand
| | - Kiattawee Choowongkomon
- Department
of Biochemistry, Faculty of Science, Kasetsart
University, Bangkok 10900, Thailand
| | - Thanyada Rungrotmongkol
- Center
of Excellence in Structural and Computational Biology Research Unit,
Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand
- Program
in
Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand
| |
Collapse
|
7
|
Divya K, Savitha D, Krishna GA, Dhanya T, Mohanan P. Crystal structure, DFT studies, Hirshfeld surface and energy framework analysis of 4-(5-nitro-thiophen-2-yl)-pyrrolo [1, 2-a] quinoxaline: A potential SARS-CoV-2 main protease inhibitor. J Mol Struct 2022; 1251:131932. [DOI: 10.1016/j.molstruc.2021.131932] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Revised: 10/07/2021] [Accepted: 11/12/2021] [Indexed: 10/19/2022]
|
8
|
Guillon J, Savrimoutou S, Albenque-rubio S, Pinaud N, Moreau S, Desplat V. Synthesis, Crystal Structure and Anti-Leukemic Activity of 1,3-Dihydro-1-{1-[4-(4-phenylpyrrolo[1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one. Molbank 2022; 2022:M1333. [DOI: 10.3390/m1333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
1,3-Dihydro-1-{1-[4-(4-phenylpyrrolo[1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one has been synthesized through a multi-step pathway starting from commercially available 2-nitroaniline. A structure characterization of this new substituted pyrrolo[1,2-a]quinoxaline compound was achieved by using FT-IR, 1H-NMR, 13C-NMR, X-Ray and HRMS spectral analysis. This new pyrroloquinoxaline derivative shows an interesting cytotoxic potential against several human leukemia cell lines (HL60, K562 and U937 cells).
Collapse
|
9
|
Hao D, Yang Z, Liu Y, Li Y, Li C, Gu Y, Vaccaro L, Liu J, Liu P. Pd-Catalyzed direct C-H arylation of pyrrolo[1,2- a]quinoxalines. Org Biomol Chem 2022; 20:847-851. [PMID: 34994375 DOI: 10.1039/d1ob02248b] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
An efficient Pd-catalyzed direct C-H arylation of pyrrolo[1,2-a]quinoxalines with aryl iodides is described, providing a selective route toward a series of 1-arylated and 1,3-diarylated pyrrolo[1,2-a]quinoxalines in good yields. This method features a broad substrate scope, good functional group tolerance and gram-scale synthesis. Furthermore, the C3-thiocyanation of the arylated product is also achieved. We believe that these novel aryl-substituted pyrrolo [1,2-a]quinoxalines will have a variety of applications in organic synthesis and medicinal chemistry.
Collapse
Affiliation(s)
- Di Hao
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Zhen Yang
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Yali Liu
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Yang Li
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Chuntian Li
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Yanlong Gu
- Key Laboratory of Material Chemistry for Energy Conversion and Storage, Ministry of Education, Hubei Key Laboratory of Material Chemistry and Service Failure, School of Chemistry and Chemical Engineering, Huazhong University of Science & Technology, Wuhan City, 430074, China
| | - Luigi Vaccaro
- Laboratory of Green S.O.C., Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi di Perugia, Perugia, Italy
| | - Jichang Liu
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| | - Ping Liu
- School of Chemistry and Chemical Engineering, the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi City, 832004, China.
| |
Collapse
|
10
|
Li S, Ren J, Ding C, Wang Y, Ma C. N, N-Dimethylformamide as Carbon Synthons for the Synthesis of N-Heterocycles: Pyrrolo/Indolo[1,2- a]quinoxalines and Quinazolin-4-ones. J Org Chem 2021; 86:16848-16857. [PMID: 34807611 DOI: 10.1021/acs.joc.1c02067] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
N,N-dimethylformamide (DMF) as synthetic precursors contributing especially the methyl, acyl, and amino groups has played a significant role in heterocycle syntheses and functionalization. In this protocol, a wide range of pyrrolo/indolo[1,2-a]quinoxalines and quinazolin-4-ones were obtained in moderate to good yields by using elemental iodine without any metal or peroxides. We considered that N-methyl and N-acyl of DMF participate and complete the reaction separately through different mechanisms, which displayed potential still to be explored of DMF.
Collapse
Affiliation(s)
- Shichen Li
- School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| | - Jianing Ren
- School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| | - Chengcheng Ding
- School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| | - Yishou Wang
- School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| | - Chen Ma
- School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China
| |
Collapse
|
11
|
Li Y, Yang Z, Liu Y, Liu Y, Gu Y, Liu P. Cu-catalyzed direct C1−H difluoromethylation of pyrrolo[1,2-a]quinoxalines. Molecular Catalysis 2021. [DOI: 10.1016/j.mcat.2021.111747] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
12
|
Abstract
We report a C3-H direct iodination of pyrrolo[1,2-a]quinoxalines with TBAI or I2; a series of novel 3-iodopyrrolo[1,2-a]quinoxaline derivatives were obtained with excellent regioselectivity and broad substrate scope. Mechanism studies show that a catalytic amount of p-toluenesulfonic acid significantly promotes the selectivity and conversion of the reaction. Notably, the reaction can be performed on a gram scale, and the iodinated products can be further transformed into potentially biologically active pyrrolo[1,2-a]quinoxaline derivatives by palladium-catalyzed coupling reactions.
Collapse
Affiliation(s)
- Yali Liu
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| | - Yu Wei
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| | - Zhen Yang
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| | - Yang Li
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| | - Yan Liu
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| | - Ping Liu
- School of Chemistry and Chemical Engineering/Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan, Shihezi University, Shihezi 832004, China.
| |
Collapse
|
13
|
Guillon J, Denevault-Sabourin C, Chevret E, Brachet-Botineau M, Milano V, Guédin-Beaurepaire A, Moreau S, Ronga L, Savrimoutou S, Rubio S, Ferrer J, Lamarche J, Mergny JL, Viaud-Massuard MC, Ranz M, Largy E, Gabelica V, Rosu F, Gouilleux F, Desplat V. Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex. Arch Pharm (Weinheim) 2021; 354:e2000450. [PMID: 33852185 DOI: 10.1002/ardp.202000450] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Revised: 03/15/2021] [Accepted: 03/18/2021] [Indexed: 11/07/2022]
Abstract
Current multiagent chemotherapy regimens have improved the cure rate in acute leukemia patients, but they are highly toxic and poorly efficient in relapsed patients. To improve the treatment approaches, new specific molecules are needed. The G-quadruplexes (G4s), which are noncanonical nucleic acid structures found in specific guanine-rich DNA or RNA, are involved in many cellular events, including control of gene expression. G4s are considered as targets for the development of anticancer agents. Heterocyclic molecules are well known to target and stabilize G4 structures. Thus, a new series of 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives (1a-i) was designed, synthesized, and evaluated against five human myeloid leukemia cell lines (K562, KU812, MV4-11, HL60, and U937). Their ability to stabilize various oncogene promoter G4 structures (c-MYC, BCL-2, and K-RAS) as well as the telomeric G4 was also determined through the fluorescence resonance energy transfer melting assay and native mass spectrometry. In addition, the more bioactive ligands 1g-i were tested for telomerase activity in HuT78 and MV4-11 protein extracts.
Collapse
Affiliation(s)
- Jean Guillon
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Caroline Denevault-Sabourin
- Groupe Innovation et Ciblage Cellulaire, UFR des Sciences Pharmaceutiques, Université Tours, EA GICC-ERL 7001 CNRS, Tours, France
| | - Edith Chevret
- Cutaneous Lymphoma Oncogenesis Team, Bordeaux Research in Translational Oncology (BaRITOn), Université Bordeaux, INSERM U1053, Bordeaux, France
| | - Marie Brachet-Botineau
- Groupe Innovation et Ciblage Cellulaire, UFR des Sciences Pharmaceutiques, Université Tours, EA GICC-ERL 7001 CNRS, Tours, France
- Service d'Hématologie Biologique, CHRU de Tours, Tours, France
| | - Vittoria Milano
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Aurore Guédin-Beaurepaire
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Stéphane Moreau
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Luisa Ronga
- Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux, Université de Pau et des Pays de l'Adour, E2S UPPA, CNRS UMR 5254, IPREM, Pau, France
| | - Solène Savrimoutou
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Sandra Rubio
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
| | - Jacky Ferrer
- Cutaneous Lymphoma Oncogenesis Team, Bordeaux Research in Translational Oncology (BaRITOn), Université Bordeaux, INSERM U1053, Bordeaux, France
| | - Jeremy Lamarche
- Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux, Université de Pau et des Pays de l'Adour, E2S UPPA, CNRS UMR 5254, IPREM, Pau, France
| | - Jean-Louis Mergny
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, UFR des Sciences Pharmaceutiques, Bordeaux, France
- Institute of Biophysics, Czech Academy of Sciences, v.v.i., Brno, Czech Republic
| | - Marie-Claude Viaud-Massuard
- Groupe Innovation et Ciblage Cellulaire, UFR des Sciences Pharmaceutiques, Université Tours, EA GICC-ERL 7001 CNRS, Tours, France
| | - Matthieu Ranz
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, Institut Européen de Chimie et Biologie, Pessac, France
| | - Eric Largy
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, Institut Européen de Chimie et Biologie, Pessac, France
| | - Valérie Gabelica
- ARNA Laboratory, Université de Bordeaux, INSERM U1212, CNRS UMR 5320, Institut Européen de Chimie et Biologie, Pessac, France
| | - Frédéric Rosu
- IECB (Institut Européen de Chimie et Biologie), Université Bordeaux, CNRS, INSERM, UMS 3033 US001, Pessac, France
| | | | - Vanessa Desplat
- Cellules souches hématopoïétiques normales et leucémiques, UFR des Sciences Pharmaceutiques, Université Bordeaux, INSERM, U1035, Bordeaux, France
| |
Collapse
|
14
|
|
15
|
Guillon J, Savrimoutou S, Rubio S, Moreau S, Pinaud N, Marchivie M, Desplat V. 1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity. Molbank 2020; 2020:M1113. [DOI: 10.3390/m1113] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one has been successfully synthesized via a multi-step pathway starting from 2-nitroaniline. Structure characterization of this original pyrrolo[1,2-a]quinoxaline derivative was achieved by FT-IR, 1H-NMR, 13C-NMR, X-Ray and HRMS spectral analysis. This title compound shows interesting cytotoxic potential against several human leukemia cell lines (K562, HL60, and U937 cells).
Collapse
|
16
|
Guillon J, Nim S, Moreau S, Ronga L, Savrimoutou S, Thivet E, Marchivie M, Di Pietro A, Prasad R, Le Borgne M. Synthesis of new piperazinyl-pyrrolo[1,2- a]quinoxaline derivatives as inhibitors of Candida albicans multidrug transporters by a Buchwald-Hartwig cross-coupling reaction. RSC Adv 2020; 10:2915-2931. [PMID: 35496110 PMCID: PMC9048445 DOI: 10.1039/c9ra09348f] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Accepted: 12/30/2019] [Indexed: 11/21/2022] Open
Abstract
Two series of piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives were prepared via a Buchwald–Hartwig cross-coupling reaction and then evaluated for their ability to inhibit the drug efflux activity of CaCdr1p and CaMdr1p transporters of Candida albicans overexpressed in a Saccharomyces cerevisiae strain. In the initial screening of twenty-nine piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives, twenty-three compounds behaved as dual inhibitors of CaCdr1p and CaMdr1p. Only four compounds showed exclusive inhibition of CaCdr1p or CaMdr1p. Further biological investigations were developed and for example, their antifungal potential was evaluated by measuring the growth of control yeast cells (AD1-8u−) and efflux pump-overexpressing cells (AD-CDR1 and AD-MDR1) after exposition to variable concentrations of the tested compounds. The MIC80 values of nineteen compounds ranging from 100 to 901 μM for AD-CDR1 demonstrated that relative resistance index (RI) values were between 8 and 274. In comparison, only seven compounds had RI values superior to 4 in cells overexpressing Mdr1p. These results indicated substrate behavior for nineteen compounds for CaCdr1p and seven compounds for CaMdr1p, as these compounds were transported via MDR transporter overexpressing cells and not by the AD1-8u− cells. Finally, in a combination assay with fluconazole, two compounds (1d and 1f) have shown a synergistic effect (fractional inhibitory concentration index (FICI) values ≤ 0.5) at micromolar concentrations in the AD-MDR1 yeast strain overexpressing CaMdr1p-protein, indicating an excellent potency toward chemosensitization. Two series of piperazinyl-pyrrolo[1,2-a]quinoxaline derivatives were prepared via a Buchwald–Hartwig cross-coupling reaction and then evaluated for their ability to inhibit the drug efflux activity of two Candida albicans transporters.![]()
Collapse
Affiliation(s)
- Jean Guillon
- Univ. Bordeaux, INSERM U1212 - UMR CNRS 5320, ARNA Laboratory, UFR des Sciences Pharmaceutiques F-33076 Bordeaux Cedex France
| | - Shweta Nim
- School of Life Sciences, Jawaharlal Nehru University 110067 New Delhi India
| | - Stéphane Moreau
- Univ. Bordeaux, INSERM U1212 - UMR CNRS 5320, ARNA Laboratory, UFR des Sciences Pharmaceutiques F-33076 Bordeaux Cedex France
| | - Luisa Ronga
- Univ. Bordeaux, INSERM U1212 - UMR CNRS 5320, ARNA Laboratory, UFR des Sciences Pharmaceutiques F-33076 Bordeaux Cedex France
| | - Solène Savrimoutou
- Univ. Bordeaux, INSERM U1212 - UMR CNRS 5320, ARNA Laboratory, UFR des Sciences Pharmaceutiques F-33076 Bordeaux Cedex France
| | - Elisabeth Thivet
- Univ. Bordeaux, INSERM U1212 - UMR CNRS 5320, ARNA Laboratory, UFR des Sciences Pharmaceutiques F-33076 Bordeaux Cedex France
| | - Mathieu Marchivie
- CNRS, Univ. Bordeaux, Bordeaux INP, ICMCB, UMR 5026 F-33608 Pessac Cedex France
| | - Attilio Di Pietro
- DRMP Group, IBCP, UMR 5086 (MMSB), CNRS/Lyon I University 69367 Lyon France
| | - Rajendra Prasad
- Amity Institute of Integrative Sciences and Health, Amity University Education Valley Gurgaon 122413 India
| | - Marc Le Borgne
- Université de Lyon, Université Claude Bernard Lyon 1, Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7 Lyon France
| |
Collapse
|
17
|
Yang Z, He J, Wei Y, Li W, Liu P, Zhao J, Wei Y. NCS-promoted thiocyanation and selenocyanation of pyrrolo[1,2-a]quinoxalines. Org Biomol Chem 2020; 18:9088-9094. [DOI: 10.1039/d0ob01818j] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
An efficient NCS-promoted thiocyanation of pyrrolo[1,2-a]quinoxalines with NH4SCN or KSCN was developed. Moreover, in the presence of KSeCN, the selenocyanation of pyrrolo[1,2-a]quinoxalines was also achieved.
Collapse
Affiliation(s)
- Zhen Yang
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Jing He
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Yueting Wei
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Weiwei Li
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Ping Liu
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Jixing Zhao
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| | - Yu Wei
- School of Chemistry and Chemical Engineering
- the Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi City
- China
| |
Collapse
|
18
|
Yang Z, He J, Wei Y, Li W, Liu P. KI/TBHP-promoted [3 + 2] cycloaddition of pyrrolo[1,2-a]quinoxalines and N-arylsulfonylhydrazones. Org Biomol Chem 2020; 18:3360-3366. [DOI: 10.1039/d0ob00494d] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
A series of diverse fused [1,2,4]triazolo[3,4-c]quinoxalines was obtained by an efficient KI/TBHP-promoted [3 + 2] cycloaddition of pyrrolo[1,2-a]quinoxalines and N-arylsulfonylhydrazones.
Collapse
Affiliation(s)
- Zhen Yang
- School of Chemistry and Chemical Engineering
- Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi
- China
| | - Jing He
- School of Chemistry and Chemical Engineering
- Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi
- China
| | - Yueting Wei
- School of Chemistry and Chemical Engineering
- Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi
- China
| | - Weiwei Li
- School of Chemistry and Chemical Engineering
- Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi
- China
| | - Ping Liu
- School of Chemistry and Chemical Engineering
- Key Laboratory for Green Processing of Chemical Engineering of Xinjiang Bingtuan
- Shihezi University
- Shihezi
- China
| |
Collapse
|
19
|
Shan Y, Li J, Zhao Y, Chen D, Li Q, You J. A Copper‐Catalyzed Three‐Component Reaction for the Preparation of Polysubstituted Pyrroles from Alkynyl Ketones, Amines and Isocyanoacetates. ChemistrySelect 2019. [DOI: 10.1002/slct.201902968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Yingying Shan
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| | - Jianming Li
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| | - Yutong Zhao
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| | - Dianpeng Chen
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| | - Qinyu Li
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| | - Jinmao You
- Chemistry and Chemical EngineeringQufu Normal University Qufu 273165, Shandong China
| |
Collapse
|
20
|
Araújo J, Menezes FG, Silva HFO, Vieira DS, Silva SRB, Bortoluzzi AJ, Sant’Anna C, Eugenio M, Neri JM, Gasparotto LHS. Functionalization of gold nanoparticles with two aminoalcohol-based quinoxaline derivatives for targeting phosphoinositide 3-kinases (PI3Kα). NEW J CHEM 2019. [DOI: 10.1039/c8nj04314k] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Quinoxaline derivatives have attracted considerable attention due to their vast range of applications that includes electroluminescence and biomedicine.
Collapse
Affiliation(s)
- Janine Araújo
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| | - Fabrício G. Menezes
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| | - Heloiza F. O. Silva
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| | - Davi S. Vieira
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| | | | - Adailton J. Bortoluzzi
- Laboratório de Bioinorgânica e Cristalografia
- Departamento de Química
- Universidade Federal de Santa Catarina
- 88040-900 Florianópolis-SC
- Brazil
| | - Celso Sant’Anna
- Laboratory of Microscopy Applied to Life Science – Lamav
- National Instituto of Metrology
- Quality and Tecnology – Inmetro
- Rio de Janeiro
- Brazil
| | - Mateus Eugenio
- Laboratory of Microscopy Applied to Life Science – Lamav
- National Instituto of Metrology
- Quality and Tecnology – Inmetro
- Rio de Janeiro
- Brazil
| | - Jannyely M. Neri
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| | - Luiz H. S. Gasparotto
- Biological Chemistry and Chemometrics Research Group
- Institute of Chemistry
- Federal University of Rio Grande do Norte
- Natal
- Brazil
| |
Collapse
|
21
|
Guillon J, Savrimoutou S, Rubio S, Desplat V. 1-Methyl-3-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole. Molbank 2018; 2018:M1023. [DOI: 10.3390/m1023] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
The 1-methyl-3-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole compound has been successfully synthesized via a multistep pathway starting from 2-phenylindole. Structure characterization of this new indole derivative was done by FTIR, 1H-NMR, 13C-NMR, and HRMS spectral analysis. The title compound showed high cytotoxic potential against five leukemia cell lines (K562, HL60, U937, U266, and Jurkat cell lines).
Collapse
|
22
|
Goel P, Alam O, Naim MJ, Nawaz F, Iqbal M, Alam MI. Recent advancement of piperidine moiety in treatment of cancer- A review. Eur J Med Chem 2018; 157:480-502. [DOI: 10.1016/j.ejmech.2018.08.017] [Citation(s) in RCA: 60] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Revised: 03/26/2018] [Accepted: 08/04/2018] [Indexed: 12/23/2022]
|
23
|
Tian Z, Xu J, Liu B, Tan Q, Xu B. Copper-Catalyzed Synthesis of Polysubstituted Pyrroles through [3+1+1] Cycloaddition Reaction of Nitrones and Isocyanides. Org Lett 2018; 20:2603-2606. [DOI: 10.1021/acs.orglett.8b00798] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Zhuang Tian
- Department of Chemistry, Innovative Drug Research Center, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China
| | - Jiaojiao Xu
- Department of Chemistry, Innovative Drug Research Center, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China
| | - Bingxin Liu
- Department of Chemistry, Innovative Drug Research Center, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China
| | - Qitao Tan
- Department of Chemistry, Innovative Drug Research Center, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China
| | - Bin Xu
- Department of Chemistry, Innovative Drug Research Center, School of Materials Science and Engineering, Shanghai University, Shanghai 200444, China
- State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China
| |
Collapse
|
24
|
Affiliation(s)
- Azam Karimian
- Department of Chemistry, Faculty of Science; University of Gonabad; Gonabad Iran
| |
Collapse
|
25
|
Hou W, Zhang G, Luo Z, Li D, Ruan H, Ruan BH, Su L, Xu H. Identification of a diverse synthetic abietane diterpenoid library and insight into the structure-activity relationships for antibacterial activity. Bioorg Med Chem Lett 2017; 27:5382-5386. [PMID: 29153424 DOI: 10.1016/j.bmcl.2017.11.014] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2017] [Revised: 11/06/2017] [Accepted: 11/08/2017] [Indexed: 01/12/2023]
Abstract
A diverse natural product-like (NPL) synthetic abietane diterpenoid library containing 86 compounds were obtained and the SARs were studied based on their antibacterial potential. Further in vitro cytotoxic and in silico drug-like properties evaluation showed that the potent antibacterial compound 84 had good drug-like properties and displayed low cytotoxicity toward noncancerous mammalian cells, indicating the study of AA and DHAA might be a good starting point for the search of novel antimicrobial molecules. Future work should be focused on the optimization of their potency and selectivity.
Collapse
Affiliation(s)
- Wei Hou
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China
| | - Guanjun Zhang
- College of Chemical Engineering and Materials Science, Tianjin University of Science & Technology, Tianjin 300457, PR China
| | - Zhi Luo
- Shanghai Evergene Biotech Co., Ltd., Shanghai 201499, PR China
| | - Di Li
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China
| | - Haoqiang Ruan
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China
| | - Benfang Helen Ruan
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China
| | - Lin Su
- College of Pharmaceutical Science, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, PR China.
| | - Hongtao Xu
- Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, PR China.
| |
Collapse
|
26
|
Abstract
This review classifies and summarizes the past 10-15 years of advancements in the field of metal-involving (i.e., metal-mediated and metal-catalyzed) reactions of oximes. These reactions are diverse in nature and have been employed for syntheses of oxime-based metal complexes and cage-compounds, oxime functionalizations, and the preparation of new classes of organic species, in particular, a wide variety of heterocyclic systems spanning small 3-membered ring systems to macroheterocycles. This consideration gives a general outlook of reaction routes, mechanisms, and driving forces and underlines the potential of metal-involving conversions of oxime species for application in various fields of chemistry and draws attention to the emerging putative targets.
Collapse
Affiliation(s)
- Dmitrii S Bolotin
- Institute of Chemistry, Saint Petersburg State University , Universitetskaya Nab., 7/9, Saint Petersburg, Russian Federation
| | - Nadezhda A Bokach
- Institute of Chemistry, Saint Petersburg State University , Universitetskaya Nab., 7/9, Saint Petersburg, Russian Federation
| | - Marina Ya Demakova
- Institute of Chemistry, Saint Petersburg State University , Universitetskaya Nab., 7/9, Saint Petersburg, Russian Federation
| | - Vadim Yu Kukushkin
- Institute of Chemistry, Saint Petersburg State University , Universitetskaya Nab., 7/9, Saint Petersburg, Russian Federation
| |
Collapse
|
27
|
Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Rubio S, Pinaud N, Bigat D, Enriquez E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J. Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a
]quinoxalinecarboxylate Derivatives on Human Leukemia Cells. ChemMedChem 2017; 12:940-953. [DOI: 10.1002/cmdc.201700049] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Revised: 02/17/2017] [Indexed: 11/09/2022]
Affiliation(s)
- Vanessa Desplat
- UFR des Sciences Pharmaceutiques; Univ. Bordeaux; 33076 Bordeaux cedex France
- INSERM U1035, Cellules souches hématopoïétiques normales et leucémiques; 33000 Bordeaux France
| | - Marian Vincenzi
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
- Department of Pharmacy and CIRPeB; University of Naples “Federico II”; Via Mezzocannone 16 80134 Naples Italy
| | - Romain Lucas
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Stéphane Moreau
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Solène Savrimoutou
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Sandra Rubio
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Noël Pinaud
- ISM-CNRS UMR 5255; Univ. Bordeaux; 351 cours de la Libération 33405 Talence cedex France
| | - David Bigat
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Elodie Enriquez
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Mathieu Marchivie
- ICMCB CNRS-UPR 9048; Univ. Bordeaux; 87 Avenue du Docteur Schweitzer 33608 Pessac cedex France
| | - Sylvain Routier
- Institut de Chimie Organique et analytique; Univ. Orleans, CNRS UMR 7311, ICOA; BP 6759, rue de Chartres 45067 Orléans cedex 2 France
| | - Pascal Sonnet
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressouces, UMR CNRS 7378, UFR de Pharmacie; Université de Picardie Jules Verne; 1 rue des Louvels 80037 Amiens cedex 01 France
| | - Filomena Rossi
- Department of Pharmacy and CIRPeB; University of Naples “Federico II”; Via Mezzocannone 16 80134 Naples Italy
| | - Luisa Ronga
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| | - Jean Guillon
- UFR des Sciences Pharmaceutiques, Univ. Bordeaux; ARNA Laboratory; 33076 Bordeaux cedex France
- INSERM U1212, UMR CNRS 5320; ARNA Laboratory; 33000 Bordeaux France
| |
Collapse
|
28
|
Keivanloo A, Soozani A, Bakherad M, Mirzaee M, Rudbari HA, Bruno G. Development of an unexpected reaction pathway for the synthesis of 1,2,4-trisubstituted pyrrolo[1,2-a]quinoxalines through palladium-catalyzed cascade reactions. Tetrahedron 2017; 73:1633-9. [DOI: 10.1016/j.tet.2017.02.018] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
29
|
Guillon J, Cohen A, Gueddouda NM, Das RN, Moreau S, Ronga L, Savrimoutou S, Basmaciyan L, Monnier A, Monget M, Rubio S, Garnerin T, Azas N, Mergny JL, Mullié C, Sonnet P. Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives. J Enzyme Inhib Med Chem 2017; 32:547-563. [PMID: 28114821 PMCID: PMC6445168 DOI: 10.1080/14756366.2016.1268608] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Novel series of bis- and tris-pyrrolo[1,2-a]quinoxaline derivatives 1 were synthesized and tested for in vitro activity upon the intraerythrocytic stage of W2 and 3D7 Plasmodium falciparum strains. Biological results showed good antimalarial activity with IC50 in the μM range. In attempting to investigate the large broad-spectrum antiprotozoal activities of these new derivatives, their properties toward Leishmania donovani were also investigated and revealed their selective antiplasmodial profile. In parallel, the in vitro cytotoxicity of these molecules was assessed on the human HepG2 cell line. Structure–activity relationships of these new synthetic compounds are discussed here. The bis-pyrrolo[1,2-a]quinoxalines 1n and 1p were identified as the most potent antimalarial candidates with selectivity index (SI) of 40.6 on W2 strain, and 39.25 on 3D7 strain, respectively. As the telomeres of the parasite could constitute an attractive target, we investigated the possibility of targeting Plasmodium telomeres by stabilizing the Plasmodium telomeric G-quadruplexes through a FRET melting assay by our new compounds.
Collapse
Affiliation(s)
- Jean Guillon
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Anita Cohen
- c UMR-MD3, Faculty of Pharmacy , Aix-Marseille University, Laboratory of Parasitology , Marseille , France
| | - Nassima Meriem Gueddouda
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Rabindra Nath Das
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Stéphane Moreau
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Luisa Ronga
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Solène Savrimoutou
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Louise Basmaciyan
- c UMR-MD3, Faculty of Pharmacy , Aix-Marseille University, Laboratory of Parasitology , Marseille , France
| | - Alix Monnier
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Myriam Monget
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Sandra Rubio
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Timothée Garnerin
- d Université de Picardie Jules Verne, Laboratoire de Glycochimie , des Antimicrobiens et des Agroressouces, UMR CNRS 7378, UFR de Pharmacie , Amiens , France
| | - Nadine Azas
- c UMR-MD3, Faculty of Pharmacy , Aix-Marseille University, Laboratory of Parasitology , Marseille , France
| | - Jean-Louis Mergny
- a ARNA Laboratory , University Bordeaux, UFR des Sciences Pharmaceutiques , Bordeaux , France.,b INSERM U1212, UMR CNRS 5320, ARNA Laboratory , Bordeaux , France
| | - Catherine Mullié
- d Université de Picardie Jules Verne, Laboratoire de Glycochimie , des Antimicrobiens et des Agroressouces, UMR CNRS 7378, UFR de Pharmacie , Amiens , France
| | - Pascal Sonnet
- d Université de Picardie Jules Verne, Laboratoire de Glycochimie , des Antimicrobiens et des Agroressouces, UMR CNRS 7378, UFR de Pharmacie , Amiens , France
| |
Collapse
|
30
|
Affiliation(s)
- Jason E. Camp
- Department of Chemical Sciences; University of Huddersfield; Queensgate Huddersfield United Kingdom
| |
Collapse
|